Biotech China 2014
Latest Research at Life Science Meetings
Lunch Break Carlos Ibanez ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
Molecular Mechanisms of Necroptosis: Old Paradigms Come Back Peter VANDENABEELE ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
Benefits of Apoptotic Cell Recognition and Cell Clearance Kodi Ravichandran ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
Lysosomes: at the Crossroad between Cell Death and Survival Boris TURK ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
Cellular Responses to Genotoxic Stress: Mechanisms and Relevance for Tumorigenesis and Cancer Treatment Jiri Bartek ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
TAp73 Regulates Tumour Angiogenesis by Promoting Hypoxia-inducible Factor-1α Degradation Gerry MELINO ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
Regulation of the RIP1 Kinase at the Crossroad of Cell Death and Inflammation Junying Yuan ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
RIP Kinases in Cell Death and Inflammation Manolis Pasparakis ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 2, 2014
Mechanisms of Colonization by the Gut Microbiome during Health and Disease Sarkis K. Mazmanian The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Collaborations in Microbiome Research Karen Nelson The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Panel Discussion: The Business of the Microbiome Mohan S. Iyer The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Building a Translational Microbiome Program Heidi Nelson The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Gut Microbial Dependence of Lupus and Antiphospholipid Syndrome Martin Kriegel The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Solution Provider Presentation: Silver Sponsor: Gut Microbiome : The Ideal T arg et for a Personalized Medicine A pproach to IBD Pierre Belichard The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Abnormal Gut Microbiome in Children with Autism vs. Controls James Adams The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Human - Microbe Interactions: Therapeutic Opportunities and Challenges James Brown The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
OMNIgene•GUT: Enabling the Scalability of Microbiome - wide Association Studies (MWAS) Carlos Merino The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Analyzing Microbiome Data: Moving from Discovery to the Bedside Bill Shannon The 2nd Microbiome/Microbiota R&D and Business Collaboration Forum October 2, 2014
Autophagy - from Neurodegeneration to the Plasma Membrane David RUBINSZTEIN ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 3, 2014
Therapeutic Modulation of Autophagy Guido Kroemer ECDO 2014 - 22nd Euroconference on Apoptosis "Cell Death & Rejuvenation" October 3, 2014
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.